197 related articles for article (PubMed ID: 37649456)
1. Bibliometric analysis on the progress of immunotherapy in renal cell carcinoma from 2003-2022.
Zhu H; Wang X; Lu S; Jianqiang W; Ou K; Li N
Hum Vaccin Immunother; 2023 Aug; 19(2):2243669. PubMed ID: 37649456
[TBL] [Abstract][Full Text] [Related]
2. Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021.
Liu K; Zhao S; Li J; Zheng Y; Wu H; Kong J; Shen Z
Front Immunol; 2022; 13():969217. PubMed ID: 35967367
[TBL] [Abstract][Full Text] [Related]
3. Bibliometric Analysis on the Progress of Chronic Heart Failure.
Wang H; Shi J; Shi S; Bo R; Zhang X; Hu Y
Curr Probl Cardiol; 2022 Sep; 47(9):101213. PubMed ID: 35525461
[TBL] [Abstract][Full Text] [Related]
4. Top 100 most-cited articles on renal cell carcinoma: A bibliometric analysis.
Zhou H; Cui F; Lv D; Gong Q; Wen J; Shuang W
Medicine (Baltimore); 2023 Feb; 102(6):e32926. PubMed ID: 36820552
[TBL] [Abstract][Full Text] [Related]
5. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
6. Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022.
Qu F; Wang G; Wen P; Liu X; Zeng X
Hum Vaccin Immunother; 2024 Dec; 20(1):2335728. PubMed ID: 38563136
[TBL] [Abstract][Full Text] [Related]
7. Global research productions pertaining to atrial fibrillation from 2004 to 2018: A bibliometric analysis.
Shi S; Shi J; Shi S; Jia Q; Yuan G; Wei Y; Wang D; Hu Y
Medicine (Baltimore); 2020 Jan; 99(5):e18971. PubMed ID: 32000426
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
9. Research trends on immunotherapy for pancreatic cancer: A bibliometric analysis.
Niu J; Jiang W; Fan D; Li X; Zhou W; Zhang H
Hum Vaccin Immunother; 2023 Dec; 19(3):2269794. PubMed ID: 37885280
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Bibliometric Analysis via CiteSpace from 2000 to 2022.
Xu J; Huang Z; Gao S; Deng G; Di J
Urol Int; 2023; 107(8):755-771. PubMed ID: 37454653
[TBL] [Abstract][Full Text] [Related]
11. Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.
Wu T; Duan Y; Zhang T; Tian W; Liu H; Deng Y
Front Biosci (Landmark Ed); 2022 Aug; 27(9):254. PubMed ID: 36224012
[TBL] [Abstract][Full Text] [Related]
12. Worldwide productivity and research trend of publications concerning tumor immune microenvironment (TIME): a bibliometric study.
Liu YG; Jiang ST; Zhang L; Zheng H; Zhang T; Zhang JW; Zhao HT; Sang XT; Xu YY; Lu X
Eur J Med Res; 2023 Jul; 28(1):229. PubMed ID: 37430294
[TBL] [Abstract][Full Text] [Related]
13. Global research landscape and trends of lung cancer immunotherapy: A bibliometric analysis.
Liu Y; Cheng X; Han X; Cheng X; Jiang S; Lin Y; Zhang Z; Lu L; Qu B; Chen Y; Zhang X
Front Immunol; 2022; 13():1032747. PubMed ID: 36532038
[TBL] [Abstract][Full Text] [Related]
14. Bibliometric and visualized analysis of the top-100 highly cited articles on immunotherapy for endometrial cancer.
Zheng W; Wu Y; Wang Y; Cheng J; Shen W
Medicine (Baltimore); 2023 Jul; 102(27):e34228. PubMed ID: 37417594
[TBL] [Abstract][Full Text] [Related]
15. Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.
Cheng K; Zhang H; Guo Q; Zhai P; Zhou Y; Yang W; Wang Y; Lu Y; Shen Z; Wu H
Front Immunol; 2022; 13():975695. PubMed ID: 36148235
[TBL] [Abstract][Full Text] [Related]
16. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis.
Wu W; Ouyang Y; Zheng P; Xu X; He C; Xie C; Hong J; Lu N; Zhu Y; Li N
Front Cell Infect Microbiol; 2022; 12():1027448. PubMed ID: 36699721
[TBL] [Abstract][Full Text] [Related]
17. Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
Huang Y; Chen Z; Shen G; Fang S; Zheng J; Chi Z; Zhang Y; Zou Y; Gan Q; Liao C; Yao Y; Kong J; Fan X
Hum Vaccin Immunother; 2024 Dec; 20(1):2318815. PubMed ID: 38419524
[TBL] [Abstract][Full Text] [Related]
18. From Bench to Bedside: How the Tumor Microenvironment Is Impacting the Future of Immunotherapy for Renal Cell Carcinoma.
Anker J; Miller J; Taylor N; Kyprianou N; Tsao CK
Cells; 2021 Nov; 10(11):. PubMed ID: 34831452
[TBL] [Abstract][Full Text] [Related]
19. Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma.
Cai XJ; Zhang HY; Zhang JY; Li TJ
J Dent Sci; 2023 Apr; 18(2):872-882. PubMed ID: 37021217
[TBL] [Abstract][Full Text] [Related]
20. Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer.
He L; Wang X; Li C; Wan Y; Fang H
Hum Vaccin Immunother; 2022 Dec; 18(1):2035552. PubMed ID: 35148255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
